Antiangiogenic factors released by the placenta, such as soluble VEGF receptor 1 (sFlt1) which antagonizes the proangiogenic proteins PlGF and VEGF in the maternal circulation, are central to the pathophysiology of preeclampsia (44–46). This evidence concerns the gene PGF and preeclampsia.